Authors:
Schinkel, J
Kroes, ACM
Wagtmans, MJ
Lamers, CBHW
van Hoek, B
Citation: J. Schinkel et al., Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays, J CLIN VIRO, 22(1), 2001, pp. 61-71
Authors:
van der Werf, MJ
Schinkel, J
van Santen, G
Vergouwe, I
Wix, RA
van Ameijden, EJ
Citation: Mj. Van Der Werf et al., Highly active antiretroviral therapy among drug users in Amsterdam: self-perceived reasons for not receiving therapy, AIDS, 13(10), 1999, pp. 1280-1281
Authors:
Schinkel, J
Langendam, MW
Coutinho, RA
Krol, A
Brouwer, M
Schuitemaker, J
Citation: J. Schinkel et al., No evidence for an effect of the CCR5 Delta 32/+ and CCR2b 64I/+ mutationson human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users, J INFEC DIS, 179(4), 1999, pp. 825-831